Avacta appoints new chief scientific officer, plans clinical trials
(Alliance News) - Avacta Group PLC on Monday said it has promoted Francis Wilson to chief scientific officer. Read More
| Price | 60.00p on 11-02-2026 at 19:15:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 61.00p |
| Sell | 59.00p |
| Last Trade: | Unknown 15,000.00 at 59.50p |
| Day's Volume: | 1,087,458 |
| Last Close: | 59.50p |
| Open: | 59.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 59.50p - 59.50p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £260.39m |
| VWAP: | 59.8976p |
| Shares in Issue: | 437.63m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 15,000 | 59.50p | OTC Trade |
17:07:45 - 11-Feb-26 |
| Sell* | 5,000 | 59.50p | Uncrossing Trade |
16:35:24 - 11-Feb-26 |
| Buy* | 817 | 60.55p | Ordinary |
16:26:46 - 11-Feb-26 |
| Buy* | 1,657 | 60.1325p | Ordinary |
16:25:42 - 11-Feb-26 |
| Buy* | 1,664 | 60.1325p | Ordinary |
16:24:23 - 11-Feb-26 |
| Buy* | 960 | 60.1325p | Ordinary |
16:24:10 - 11-Feb-26 |
| Buy* | 60,000 | 60.1125p | Ordinary |
16:21:31 - 11-Feb-26 |
| Buy* | 20,000 | 60.1125p | Ordinary |
16:20:39 - 11-Feb-26 |
| Buy* | 25,000 | 61.00p | Ordinary |
16:19:00 - 11-Feb-26 |
| Sell* | 59,000 | 59.87p | Ordinary |
16:18:22 - 11-Feb-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Feb 2026 7:00 am | RNS | Appointment of CSO |
| 3rd Feb 2026 7:00 am | RNS | Faridoxorubicin Program Clinical Updates |
| 21st Jan 2026 7:00 am | RNS | FDA Clearance of IND Application for AVA6103 |
| 20th Jan 2026 7:01 am | RNS | Year-end trading update |
| 20th Jan 2026 7:00 am | RNS | Appointment of Nominated Adviser & TVR |
| 18th Dec 2025 7:00 am | RNS-R | Avacta reports new AVA6103 pharmacology data |
| 17th Dec 2025 7:00 am | RNS | Faridoxorubicin Phase 1b SGC data |
| 8th Dec 2025 7:00 am | RNS | Preliminary Data in Faridoxorubicin Phase 1b Trial |
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |